Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the disease COVID-19 that has decimated the health and economy of our planet. The virus causes the disease not only in people but also in companion and wild animals. As yet we do not know why the virus is highly successful in causing the pandemic within 3 months of its first report. Lack of a voice on how to handle the pandemic impacted the management of the disease globally. Publication of the importance of masks and social distancing in preprint servers reduced the spread of the disease and deaths associated with it. Very few countries have invested in science and research and development and that has impacted the development of therapies for the pandemic. Though vaccination against COVID-19 started in December 2020, slower rate of immunizations has resulted in rapid spread of the mutant strains of SARS-CoV-2. Lack of transparency and accountability coupled with anergic leadership was responsible for the high incidence of disease and death associated with the COVID-19 pandemic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Change history
01 January 2022
A correction has been published.
References
Yang X, Zhao J, Yan Q, Zhang S, Wang Y, Li Y (2020) A case of COVID-19 patient with the diarrhea as initial symptom and literature review. Clin Res Hepatol Gastroenterol 44(5):e109–e112
Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M, Hilbe R, Seiwald S, Scholl-Buergi S, Fritsche G, Bellmann-Weiler R, Weiss G, Müller T, Adolph TE, Tilg H (2020) Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut 69:1543–1544
Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M (2020) Presumed asymptomatic carrier transmission of COVID-19. JAMA 323:1406–1407
Gao Z, Xu Y, Sun C et al (2020) A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect 54:12–16
Thomas S (2020) The structure of the membrane protein of SARS-CoV-2 resembles the sugar transporter SemiSWEET. Pathog Immun 5(1):342–363
Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF, Cai HL, Qiu YQ, Li LJ (2020) Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 368:m606
Green A (2020) Li Wenliang. Lancet 395:682
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrobial Agents 55:105924
Zhang C, Zheng W, Huang X, Bell EW, Zhou X, Zhang Y (2020) Protein structure and sequence reanalysis of 2019-nCoV genome refutes snakes as its intermediate host and the unique similarity between its spike protein insertions and HIV-1. J Proteome Res 19:1351–1360
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273
Liu P, Jiang J-Z, Wan X-F, Hua Y, Li L, Zhou J et al (2020) Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? PLoS Pathog 16(5):e1008421
Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou JJ, Li N, Guo Y, Li X, Shen X, Zhang Z, Shu F, Huang W, Li Y, Zhang Z, Chen RA, Wu YJ, Peng SM, Huang M, Xie WJ, Cai QH, Hou FH, Chen W, Xiao L, Shen Y (2020) Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. Nature 583:286–289
Oude Munnink BB, Sikkema RS, Nieuwenhuijse DF, Molenaar RJ, Munger E, Molenkamp R, van der Spek A, Tolsma P, Rietveld A, Brouwer M, Bouwmeester-Vincken N, Harders F, Hakze-van der Honing R, Wegdam-Blans MCA, Bouwstra RJ, GeurtsvanKessel C, van der Eijk AA, Velkers FC, Smit LAM, Stegeman A, van der Poel WHM, Koopmans MPG (2021) Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science 371:172–177
McAloose D, Laverack M, Wang L, Killian ML, Caserta LC, Yuan F, Mitchell PK, Queen K, Mauldin MR, Cronk BD, Bartlett SL, Sykes JM, Zec S, Stokol T, Ingerman K, Delaney MA, Fredrickson R, Ivančić M, Jenkins-Moore M, Mozingo K, Franzen K, Bergeson NH, Goodman L, Wang H, Fang Y, Olmstead C, McCann C, Thomas P, Goodrich E, Elvinger F, Smith DC, Tong S, Slavinski S, Calle PP, Terio K, Torchetti MK, Diel DG (2020) From people to Panthera: natural SARS-CoV-2 infection in tigers and lions at the Bronx zoo. mBio 11(5):e02220-20
Sia SF, Yan LM, Chin AWH, Fung K, Choy KT, Wong AYL et al (2020) Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature 583:834–838
Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B et al (2020) Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science 368:1016–1020
Wang Z, Fu Y, Guo Z, Li J, Li J, Cheng H, Lu B, Sun Q (2020) Transmission and prevention of SARS-CoV-2. Biochem Soc Trans 48(5):2307–2316
Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, Guo Q, Sun X, Zhao D, Shen J, Zhang H, Liu H, Xia H, Tang J, Zhang K, Gong S (2020) Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med 26(4):502–505
Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, Ravelli RBG, Paul van Schayck J, Mykytyn AZ, Duimel HQ, van Donselaar E, Riesebosch S, Kuijpers HJH, Schipper D, van de Wetering WJ, de Graaf M, Koopmans M, Cuppen E, Peters PJ, Haagmans BL, Clevers H (2020) SARS-CoV-2 productively infects human gut enterocytes. Science 369:50–54
Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MMG, Spijker R, Hooft L, Emperador D, Dittrich S, Domen J, Horn SRA, Van den Bruel A (2020) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev 7:CD013665
Caballero AE, Ceriello A, Misra A, Aschner P, McDonnell ME, Hassanein M, Ji L, Mbanya JC, Fonseca VA (2020) COVID-19 in people living with diabetes: an international consensus. J Diabetes Complicat 34:107671
Huang I, Lim MA, Pranata R (2020) Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 14:395–403
Ceriello A (2020) Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory. Diabetes Res Clin Pract 163:108186
Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X, Yu X, Dong K (2020) Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care 8(1):e001343
Chen J, Wu C, Wang X, Yu J, Sun Z (2020) The impact of COVID-19 on blood glucose: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 11:574541
Peters MC, Sajuthi S, Deford P, Christenson S, Rios CL, Montgomery MT et al (2020) COVID-19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids. Am J Respir Crit Care Med 202:83–90
Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z (2020) ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol 18:2128–2130.e2
Mallapaty S (2020) Mounting clues suggest the coronavirus might trigger diabetes. Nature 583:16–17
Zhang Y, Li H, Zhang J, Cao Y, Zhao X, Yu N et al (2020) The clinical characteristics and outcomes of diabetes mellitus and secondary hyperglycemia patients with coronavirus disease 2019: a single-center, retrospective, observational study in Wuhan. Diabetes Obes Metab 22:1443–1454
Jiang B, Wei H (2020) Oxygen therapy strategies and techniques to treat hypoxia in COVID-19 patients. Eur Rev Med Pharmacol Sci 24:10239–10246
Liu L, Cai D, Huang X, Shen Y (2021) COVID-2019 associated with acquired monocular blindness. Curr Eye Res 3:1–4
Centers for Disease Control and Prevention (2021) Fungal diseases. About mucormycosis. Retrieved from: https://www.cdc.gov/fungal/diseases/mucormycosis/definition.html
Sharma S, Grover M, Bhargava S, Samdani S, Kataria T (2021) Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol 8:1–6
Centers for Disease Control and Prevention (2021) Fungal diseases and Covid-19. Retrieved from: https://www.cdc.gov/fungal/covid-fungal.html
Villanueva-Lozano H, Treviño-Rangel RJ, González GM, Ramírez-Elizondo MT, Lara-Medrano R, Aleman-Bocanegra MC, Guajardo-Lara CE, Gaona-Chávez N, Castilleja-Leal F, Torre-Amione G, Martínez-Reséndez MF (2021) Outbreak of Candida auris infection in a COVID-19 hospital in Mexico. Clin Microbiol Infect 27:813–816
Brian DA, Baric RS (2005) Coronavirus genome structure and replication. Curr Top Microbiol Immunol 287:1–30
Thomas S (2021) Mapping the non-structural transmembrane proteins of SARS-CoV-2. J Comp Biol 28:909–921
Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, Graham BS, Mc-Lellan JS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367:1260–1263
Amraie R, Napoleon MA, Yin W et al (2020) CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells. Preprint. bioRxiv 2020;2020.06.22.165803
Belov GA, van Kuppeveld FJ (2012) (+)RNA viruses rewire cellular pathways to build replication organelles. Curr Opin Virol 2(6):740–747
Ghosh AK, Brindisi M, Shahabi D, Chapman ME, Mesecar AD (2020) Drug development and medicinal chemistry efforts toward SARS-coronavirus and Covid-19 therapeutics. Chem Med Chem 15:907–932
Centers for Disease Control and Prevention (2021) Emerging SARS-CoV-2 variants. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html
Zhang W, Davis BD, Chen SS, Sincuir Martinez JM, Plummer JT, Vail E (2021) Emergence of a novel SARS-CoV-2 variant in Southern California. JAMA 325:1324–1326
Edara VV, Lai L, Sahoo MK, Floyd K, Sibai M, Solis D, Flowers MW, Hussaini L, Ciric CR, Bechnack S, Stephens K, Mokhtari EB, Mudvari P, Creanga A, Pegu A, Derrien-Colemyn A, Henry AR, Gagne M, Graham BS, Wrammert J, Douek DC, Boritz E, Pinsky BA, Suthar MS (2021) Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant. bioRxiv (Preprint). 2021.05.09.443299
New York Times (2020). Retrieved from https://www.nytimes.com/2020/03/29/world/asia/coronavirus-india-migrants.html
Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, Prodonoff JS, Carregari VC, de Biagi Junior CAO, Crunfli F, Jimenez Restrepo JL, Vendramini PH, Reis-de-Oliveira G, Bispo Dos Santos K, Toledo-Teixeira DA, Parise PL, Martini MC, Marques RE, Carmo HR, Borin A, Coimbra LD, Boldrini VO, Brunetti NS, Vieira AS, Mansour E, Ulaf RG, Bernardes AF, Nunes TA, Ribeiro LC, Palma AC, Agrela MV, Moretti ML, Sposito AC, Pereira FB, Velloso LA, Vinolo MAR, Damasio A, Proença-Módena JL, Carvalho RF, Mori MA, Martins-de-Souza D, Nakaya HI, Farias AS, Moraes-Vieira PM (2020) Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab 32:437–446.e5
Ngonghala CN, Iboi E, Eikenberry S, Scotch M, MacIntyre CR, Bonds MH, Gumel AB (2020) Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel coronavirus. Math Biosci 325:108364
Howard J, Huang A, Li Z, Tufekci Z, Zdimal V, van der Westhuizen HM, von Delft A, Price A, Fridman L, Tang LH, Tang V, Watson GL, Bax CE, Shaikh R, Questier F, Hernandez D, Chu LF, Ramirez CM, Rimoin AW (2021) An evidence review of face masks against COVID-19. Proc Natl Acad Sci U S A 118:e2014564118
Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ (2020) COVID-19 systematic urgent review group effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta–analysis. Lancet 395:1973–1987
CNBC (2021). Retrieved from https://www.cnbc.com/2021/02/26/israeli-data-suggest-mass-vaccinations-led-to-drop-in-severe-covid-cases-cdc-study-finds.html
Moutinho S (2021) Syringe size and supply issues continue to waste COVID-19 vaccine doses in United States. Retrieved from: https://www.sciencemag.org/news/2021/03/syringe-size-and-supply-issues-continue-waste-covid-19-vaccine-doses-united-states
Olsen SJ, Azziz-Baumgartner E, Budd AP et al (2020) Decreased influenza activity during the COVID-19 pandemic — United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep 69:1305–1309
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Thomas, S. (2022). Status of COVID-19 Pandemic Before the Administration of Vaccine. In: Thomas, S. (eds) Vaccine Design. Methods in Molecular Biology, vol 2410. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1884-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1884-4_4
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1883-7
Online ISBN: 978-1-0716-1884-4
eBook Packages: Springer Protocols